245 related articles for article (PubMed ID: 21625939)
21. Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Marutsuka K; Hatakeyama K; Sato Y; Yamashita A; Sumiyoshi A; Asada Y
Thromb Res; 2002 Sep; 107(5):271-6. PubMed ID: 12479889
[TBL] [Abstract][Full Text] [Related]
22. Tissue factor enhances protease-activated receptor-2-mediated factor VIIa cell proliferative properties.
Fan L; Yotov WV; Zhu T; Esmailzadeh L; Joyal JS; Sennlaub F; Heveker N; Chemtob S; Rivard GE
J Thromb Haemost; 2005 May; 3(5):1056-63. PubMed ID: 15869604
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway.
Hu W; Li F; Mahavadi S; Murthy KS
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1310-20. PubMed ID: 19369446
[TBL] [Abstract][Full Text] [Related]
24. Cigarette smoke extract promotes human vascular smooth muscle cell proliferation and survival through ERK1/2- and NF-κB-dependent pathways.
Chen QW; Edvinsson L; Xu CB
ScientificWorldJournal; 2010 Nov; 10():2139-56. PubMed ID: 21057728
[TBL] [Abstract][Full Text] [Related]
25. FVIIa prevents the progressive hemorrhaging of a brain contusion by protecting microvessels via formation of the TF-FVIIa-FXa complex.
Yuan Q; Zhang D; Wu S; Yu J; Yu L; Sun Y; Du Z; Li Z; Zhou L; Wu X; Hu J
Neuroscience; 2017 Apr; 348():114-125. PubMed ID: 28223242
[TBL] [Abstract][Full Text] [Related]
26. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
Rothmeier AS; Liu E; Chakrabarty S; Disse J; Mueller BM; Østergaard H; Ruf W
Blood; 2018 Feb; 131(6):674-685. PubMed ID: 29246902
[TBL] [Abstract][Full Text] [Related]
27. Cortactin activation by FVIIa/tissue factor and PAR2 promotes endothelial cell migration.
Zhu T; Mancini JA; Sapieha P; Yang C; Joyal JS; Honoré JC; Leduc M; Zaniolo K; Hardy P; Shao Z; Fan L; Hou X; Rivard GE; Chemtob S
Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R577-85. PubMed ID: 21160057
[TBL] [Abstract][Full Text] [Related]
28. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
[TBL] [Abstract][Full Text] [Related]
29. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
Jiang X; Zhu S; Panetti TS; Bromberg ME
Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
[TBL] [Abstract][Full Text] [Related]
30. Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling.
Mandal SK; Pendurthi UR; Rao LV
Blood; 2007 Jul; 110(1):161-70. PubMed ID: 17384202
[TBL] [Abstract][Full Text] [Related]
31. Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.
Jiang R; Wang NP; Tanaka KA; Levy JH; Guyton RA; Zhao ZQ; Vinten-Johansen J
J Surg Res; 2011 Aug; 169(2):319-27. PubMed ID: 20451919
[TBL] [Abstract][Full Text] [Related]
32. Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion.
Paul S; Das K; Ghosh A; Chatterjee A; Bhoumick A; Basu A; Sen P
J Thromb Haemost; 2023 Dec; 21(12):3522-3538. PubMed ID: 37579880
[TBL] [Abstract][Full Text] [Related]
33. Apixaban Suppresses the Release of TF-Positive Microvesicles and Restrains Cancer Cell Proliferation through Directly Inhibiting TF-fVIIa Activity.
Featherby S; Madkhali Y; Maraveyas A; Ettelaie C
Thromb Haemost; 2019 Sep; 119(9):1419-1432. PubMed ID: 31266079
[TBL] [Abstract][Full Text] [Related]
34. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.
Wiiger MT; Prydz H
Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840
[TBL] [Abstract][Full Text] [Related]
35. Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.
Chanakira A; Westmark PR; Ong IM; Sheehan JP
Gynecol Oncol; 2017 Apr; 145(1):167-175. PubMed ID: 28148395
[TBL] [Abstract][Full Text] [Related]
36. Proteinase-activated receptors induce interleukin-8 expression by intestinal epithelial cells through ERK/RSK90 activation and histone acetylation.
Wang H; Moreau F; Hirota CL; MacNaughton WK
FASEB J; 2010 Jun; 24(6):1971-80. PubMed ID: 20065107
[TBL] [Abstract][Full Text] [Related]
37. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
38. The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.
Carneiro-Lobo TC; Schaffner F; Disse J; Ostergaard H; Francischetti IM; Monteiro RQ; Ruf W
J Thromb Haemost; 2012 Sep; 10(9):1849-58. PubMed ID: 22823596
[TBL] [Abstract][Full Text] [Related]
39. PAR-2 activation in intestinal epithelial cells potentiates interleukin-1beta-induced chemokine secretion via MAP kinase signaling pathways.
Fyfe M; Bergström M; Aspengren S; Peterson A
Cytokine; 2005 Sep; 31(5):358-67. PubMed ID: 16095910
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G
J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
